Home
>
National Drug Code (NDC)
>
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN - 10544-513-20 - (PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN)
Drug Information of PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
| Product NDC: | 10544-513 |
| Proprietary Name: | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN |
| Non Proprietary Name: | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN |
| Active Ingredient(s): | 650; 100 mg/1; mg/1 & nbsp; PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
| Product NDC: | 10544-513 |
| Labeler Name: | Blenheim Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075738 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100511 |
Package Information of PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
| Package NDC: | 10544-513-20 |
| Package Description: | 20 TABLET in 1 BOTTLE (10544-513-20) |
NDC Information of PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
| NDC Code | 10544-513-20 |
| Proprietary Name | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN |
| Package Description | 20 TABLET in 1 BOTTLE (10544-513-20) |
| Product NDC | 10544-513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100511 |
| Marketing Category Name | ANDA |
| Labeler Name | Blenheim Pharmacal, Inc. |
| Substance Name | ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE |
| Strength Number | 650; 100 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
